Figure 4.
Kaplan–Meier estimator for PFS for patients with a > 21.4% decrease in cloudy‐enhancing compartment at first follow‐up (TP1) compared to baseline (solid line) and patients with a < 21.4% decrease in cloudy‐enhancing compartment at first follow‐up compared to baseline (dotted line). PFS, progression‐free survival.